Summary: Pairs of forward and reverse primers and TaqMan probes specific to each of 19 drug-metabolizing enzymes (cytochrome P450s, UDP-glucuronosyltransferases, glutathione S-transferases, and sulfotransferases) and 5 transporters (ABC and SLC transporters) in the cynomolgus monkey were prepared. The expression level of each target mRNA was analyzed in total RNA obtained from three specimens of various cynomolgus monkey tissues (adrenal gland, brain, heart, kidney, large intestine, liver, lung, pancreas, prostate, small intestine, spleen, testis, and thymus) by real-time reverse transcription PCR using an Applied Biosystems 7500 Fast Real-Time PCR System. The data obtained in the present study provide useful information on tissue-specific profiles of the expression of these target mRNAs in the cynomolgus monkey, and the results are expected to be valuable in establishing drug metabolism-and transporter-mediated screening systems using the cynomolgus monkey for the evaluation of new chemical entities in new drug development.
Introduction
The cynomolgus monkey is a commonly used species for biotransformation and drug-safety evaluation studies in the pharmaceutical industry. Therefore, investigation of the tissue-specific mRNA expression profiles of drugmetabolizing enzymes, transporters, etc. can be expected to provide important information in pharmacokinetic studies involving the distribution, metabolism and elimination of drugs and in toxicological studies of processes containing detoxification.
cDNAs encoding drug-metabolizing enzymes such as the cytochrome P450s [1] [2] [3] [4] and UDP-glucuronosyltransferases 5) and cDNAs encoding transporters such as MRP1 6) have been cloned from the cynomolgus monkey. We previously reported the tissue distribution of mRNA expression of large numbers of drug-metabolizing enzymes 7, 8) and transporters in humans. [9] [10] [11] However, the tissue distribution of the mRNA expression of large numbers of drug-metabolizing enzymes and transporters has not been evaluated under the same experimental conditions in the cynomolgus monkey.
The present study was therefore undertaken to investigate the mRNA expression levels of 24 drug-metabolizing enzymes and transporters in the cynomolgus monkey using high-sensitivity real-time reverse transcription PCR (RT-PCR) in total RNA obtained from 13 tissues of three adult male cynomolgus monkeys.
Materials and Methods
Materials: Yeast tRNA was purchased from Life Technologies, Inc. (Rockville, MD, USA), the RNeasy  Lipid Tissue Mini Kit was purchased from QIAGEN (Hilden, Germany), and the TaqMan One-Step RT-PCR Master Mix Reagents Kit was purchased from Applied Biosystems (Foster City, CA, USA). All other chemicals Oligonucleotides: The pairs of forward and reverse primers and TaqMan probes for the cynomolgus monkey used in the RT-PCR sequences were designed using Primer Express software (ver. 1.5, Applied Biosystems). Each primer and probe were homology-searched by an NCBI BLAST search to ensure they were specific to the target mRNA transcript. The pairs of forward and reverse primers and the TaqMan probes used for RT-PCR analysis are listed in Table 2 . Other pairs of forward and reverse primers and probes have been reported elsewhere. 12, 13) The GenBank accession number and position from the initiation codon are also shown in Table 2 . The primers and TaqMan probes were synthesized by the Genosys Division of Sigma-Aldrich Japan K.K. (Ishikari, Hokkaido, Japan). The TaqMan probes contained 6-carboxyfluorescein (FAM) at the 5? end and 6-carboxytetramethylrhodamine (TAMRA) at the 3? end and were designed to hybridize to a sequence located between the PCR primers.
TaqMan RT-PCR conditions: Total RNA samples obtained from adult cynomolgus monkey tissues were diluted to 10 mg/mL with RNase-free water containing 50 mg/mL yeast tRNA. Total RNA at 30 ng per 20 mL of reaction mixture was used for measurement of target mRNA in each tissue. For the RT-PCR reaction, the TaqMan One-Step RT-PCR Master Mix Reagents Kit (Applied Biosystems) containing 300 nM forward primer, 900 nM reverse primer, and 200 nM TaqMan probe was used at 20 mL/tube. RT-PCR assay was performed using the Applied Biosystems 7500 Fast Real-Time PCR System (Applied Biosystems) with the following profile: 1 cycle at 48 9 C for 30 min, 1 cycle at 959 C for 10 min, and 40 cycles each at 959 C for 15 sec and 609 C for 1 min. The threshold cycle (Ct) was calculated by the instrument software (7500 Fast System ver. 1.3.1).
Data analysis: As shown in Table 3 , the relative expression of each housekeeping gene mRNA was calculated by the DCt method (where DCt is the value obtained by subtracting Ct of the target mRNA in the liver from Ct of the target mRNA in each tissue). Specifically, the amount of target mRNA in each tissue relative to target mRNA in the liver is expressed as 2 -(DCt) . As shown in Tables 4-8 , the relative expression of each drugmetabolizing enzyme or transporter mRNA was calculated by the DCt method (where DCt is the value obtained by subtracting Ct of PGK1 mRNA from Ct of the target mRNA), as in previous studies. 14) Data are expressed as the ratio of target mRNA in each tissue to the target mRNA in the liver. Experiments were performed in duplicate and mean values were calculated. Further, data are shown as means±SD for the three cynomolgus monkeys.
Results and Discussion
The data obtained in this study provide information on tissue-specific profiles of the mRNA expression of seven cytochrome P450s (CYP1A1, CYP1A2, CYP2D17, CYP2E1, CYP2J2, CYP3A5, and CYP3A8), eight UDPglucuronosyltransferases (UGT1A1, UGT1A6, UGT1A8, UGT1A9, UGT2B9, UGT1B18, UGT1B20, and UGT1B30), two glutathione S-transferases (GSTM1 and GSTM2), two sulfotransferases (HST and PST), and five transporters (MDR1, MRP1, MRP2, PEPT1, and OATP1B3) in the cynomolgus monkey. Table 3 shows the relative amounts of housekeeping gene mRNAs in each tissue used. Data are expressed as the ratio to the value in the liver for each housekeeping gene. For example, the expression of b-actin mRNA was 48-fold higher in the large intestine than pancreas, and the expression of GAPDH mRNA was 64-fold higher in the heart than pancreas. The expression of PGK1 mRNA showed the smallest variation among the housekeeping genes studied. Therefore, consistent with the findings of our previous studies, 9) we considered PGK1 mRNA to be a suitable endogenous control for measurement of mRNA expression. The process used to select the best housekeeping gene is described in detail in our previous studies.
14)
The mRNA expression levels of seven CYP isoforms in various cynomolgus monkey tissues are shown in Table  4 . As for the tissue distribution of CYP mRNAs (Table  4) , the liver was commonly the organ in which the highest mRNA expression levels were observed for all of cynomolgus monkey CYP isoforms examined. The mRNA expression levels of CYP isoforms in the liver were in the order CYP3A8À ÀCYP2E1ÀCYP2D17AE CYP2J2AECYP3A5À ÀCYP1A1À À ÀCYP1A2. The small intestine showed the second-highest mRNA expression levels of four CYP isoforms (CYP1A1, CYP2J2, CYP3A5, and CYP3A8). It should be noted that the mRNA expression level of CYP1A2 was much lower than that of CYP1A1, which is opposite the case for the mRNA expression levels of human CYP1A1 and CYP1A2. 7) Sakuma et al. 2) also reported that the mRNA expression level of CYP1A was highest in the liver in cynomolgus monkeys. The expression profiles of CYP2J2, CYP3A5, and CYP3A8 mRNAs in cynomolgus monkeys were similar to those of CYP2J2, CYP3A5, and CYP3A4 in humans, respectively.
7)
The mRNA expression levels of eight UGT isoforms in various cynomolgus monkey tissues are shown in Table  5 . The mRNA expression levels of six UGT isoforms Table 4 .
Expression of cytochrome P450 mRNAs in various cynomolgus monkey tissues Data are expressed as the ratio of the target mRNA to PGK1 mRNA. Experiments were performed in duplicate, and the mean values were calculated. Further, data are shown as means±SD for the three cynomolgus monkeys. The highest values among the various tissues are shown in boxes. Data are expressed as the ratio of the target mRNA to PGK1 mRNA. Experiments were performed in duplicate, and the mean values were calculated. Further, data are shown as means±SD for the three cynomolgus monkeys. The highest values among the various tissues are shown in boxes. were highest in the liver, whereas those of two isoforms were highest in the large intestine. The mRNA expression levels of UGT isoforms in the liver and large intestine were found to be in the order UGT2B9ÀUGT1A8 ＝ UGT1A9 AE UGT1A6 AE UGT1B20 À UGT1B18 À UGT1B30ÀUTG1A1. In addition to the liver and large intestine, the small intestine, kidney, and testis also showed relatively high mRNA expression levels of UGT isoforms. The mRNA expression levels of two GST isoforms (GSTM1 and GSTM2) were also examined. The mRNA expression level of GSTM1 was highest in the testis, while that of GSTM2 was highest in the liver, with the former much lower than the latter ( Table 6 ). With regard to SULT isoforms, the mRNA expression levels were measured for two isoforms: HST and PST ( Table  7) . The mRNA expression levels of both SULT isoforms were found to be highest in the liver, in the order PSTÀHST. The mRNA expression levels of five transporters are summarized in Table 8 . The mRNA expression levels of MRP2 and OATP1B3 were highest in the liver, the mRNA expression level of MDR1 was highest in the large intestine, that of MRP1 was highest in the testis and that of PEPT1 was highest in the small intestine. The mRNA expression levels of MDR1, MRP1, and MRP2 were also relatively high in other tissues such as the small intestine and adrenal gland for MDR1, the lung and large intestine for MRP1 and the small intestine and kidney for MRP2. In contrast, PEPT1 mRNA and OATP1B3 mRNA were found to be expressed exclusively in the small intestine and liver, respectively. Takahashi et al. 15) reported that the mRNA expression levels of MDR1 and MRP2 in cynomolgus monkey intestine were significantly higher than those in the human intestine.
In the present study, the standard error of the measurement results for many target mRNAs was very large. In previous studies concerning drug-metabolizing enzymes 8) and SLC transporters 10, 11) in humans, although results were reported for only the liver, the mRNA expression levels of many target genes were found to differ by a factor of 10 or more. We therefore feel that differences of this magnitude reflect the range of variation in mRNA expression levels.
Bleasby et al. 16) have reported expression profiles of numerous xenobiotic transporter genes, providing valuable information for a large number of targets, a large number of tissues and a large number of species. However, the real-time RT-PCR method is quantitatively superior to the microarray method. We have already reported data concerning tissue expression profiles of drug-metabolizing enzymes and transporters in humans, which in turn has made it possible to obtain measurements. [7] [8] [9] [10] [11] The present study investigates the mRNA expression profiles of many targets in the cynomolgus monkey using the measurement system we have established. Although the RT-PCR method may be inferior to the microarray method in terms of the amount of information that can be acquired at one time, we feel that the information obtained using the former method can serve as an extremely useful database of individual findings.
In conclusion, the results of this study provide information concerning the tissue-specific profiles of the mRNA expression of 19 drug-metabolizing enzymes and 5 transporters in the cynomolgus monkey. The results are expected to be valuable in establishing drug metabolism-and transporter-mediated screening systems using the cynomolgus monkey for evaluation of new chemical entities in new drug development. In particular, the information in this study is expected to be important in assessing the feasibility of measuring the mRNA expression levels of target genes in various tissues.
